**Weekly News Sentiment:** Neutral to Negative

**Notable Events:**

1. Sun Pharma's Q4 results: Profit declined 19% YoY, and the company declared a dividend of ₹5.50 per share.
2. The company announced Jayashree Satagopan as its incoming CFO.
3. JM Financial retained a "Buy" rating on Sun Pharma, but lowered its target price to ₹2,025.

**News Tone:**

The overall news tone for Sun Pharma is neutral to negative this week. The company's Q4 results were disappointing, with a 19% decline in profit, which led to a fall in its share price. The announcement of a new CFO and the retention of a "Buy" rating by JM Financial were positive developments, but they were not enough to offset the negative sentiment surrounding the Q4 results.

The historical data suggests that similar news events have had a mixed impact on Sun Pharma's stock price in the past. However, the current week's news tone is more negative than positive, indicating that the stock may face some pressure in the short term.